Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance

...th's key pharmaceutical franchises PREVNAR ((R)),( ) ENBREL ((R)) (outside the U.S. and Canada) and Nutritional products, along with higher sales of pristiq ((R)), TYGACIL ((R)), TORISEL ((R)) and the Hemophilia family and higher Enbrel alliance revenue. These increases were partially offset by decrease...

Lexapro Loses First-Line Position for the Treatment of Major Depression

...sion Resources Patient-Flow Forecasts Between pristiq and Effexor XR Need to Take Into Account Reimburse...all patients in our claims database taking Wyeth's pristiq for major depression, only 2.6 percent took the drug on the first line. Among patients moving to pristiq from another drug, 13.0 percent had taken Wyeth's ...

Wyeth Reports Earnings Results for the 2009 First Quarter

...key pharmaceutical franchises ENBREL (R) (outside the U.S. and Canada), PREVNAR (R) and Nutritional products, along with new products TYGACIL (R), pristiq (R) and TORISEL (R), as well as PROTONIX (R). These increases were partially offset by lower ENBREL alliance revenue, due primarily to the 2008...

Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies

...ll-scale selling and educational efforts regarding pristiq for physicians this week. "We are proud to make pristiq available as a new treatment option for the millio...Neuroscience. "The recommended therapeutic dose of pristiq is 50 mg once daily. Titration is not required to ...

More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms

...that could cause actual results to differ materially from those expressed or implied by such statements. In particular, there can be no assurance that pristiq (desvenlafaxine) will be commercially successful in the highly competitive market for antidepressants in the United States, or that desvenlafaxine wil...

New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies

... of pharmacotherapies for depression. Drugs/Companies mentioned in this report include: Effexor (venlafaxine; Wyeth), Lexapro (escitalopram; Forest), pristiq (o-desmethylvenlafaxine; Wyeth), Cymbalta (duloxetine; Lilly), Wellbutrin (bupropion; GlaxoSmithKline), Valdoxan (agomelatine; Novartis/Servier), bife...

Pristiq in Medical Technology

Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats

... First Scientific Presentation for pristiq Occurs at the 55th Annual Clinical Meeting of the ...enopause. These studies showed that women who took pristiq experienced a reduction in both the number and sev...s. Additional analyses presented demonstrated that pristiq reduced the number of nighttime awakenings and moo...

Pristiq in Biological Technology

New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo

Data Presented for the First Time on 50 mg/Day Dose for PRISTIQ for the Treatment of Major Depressive Disorder COLLEGEVILLE, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announces that data from two Phase 3 clinical studies of...

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

...en by continued growth in its core franchises, Enbrel, Prevnar and Nutritionals, and increased contribution from its newer products, Tygacil, Torisel, pristiq and Relistor. This solid growth is helping to offset the expected declines of products with emerging generic competition. The Company will report it...

FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder

...ve disorder (MDD). Wyeth expects to begin shipping pristiq to wholesalers beginning in the second quarter of 2008. "We are pleased to be able to bring pristiq to patients," says Bernard Poussot, President and ...nal non-clinical toxicity study. The efficacy of pristiq as a treatment for depression was established in f...